Study of Veliparib in Combination With Nivolumab and Platinum Doublet Chemotherapy in Participants With Metastatic or Advanced Non-Small Cell Lung Cancer (NSCLC)
Clinical trial NCT02944396 · COMPLETED
Trial details
- NCT number
- NCT02944396
- Sponsor
- AbbVie
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2016-12-23
- Primary completion
- 2019-10-02
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.